Literature DB >> 24053634

Opportunities for deprescribing statins in patients with poor cancer prognosis.

Justin Turner1, Nimit Singhal, J Simon Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24053634     DOI： 10.1089/jpm.2013.0278

Source DB:  PubMed          Journal:  J Palliat Med        ISSN： 1557-7740            Impact factor:   2.947


× No keyword cloud information.
  4 in total

Review 1.  Deprescribing for older patients.

Authors:  Christopher Frank; Erica Weir
Journal:  CMAJ       Date:  2014-09-02       Impact factor: 8.262

2.  The role of the OncPal deprescribing guideline in end-of-life care.

Authors:  Emily Reeve; Danijela Gnjidic; Sarah Hilmer
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

Review 3.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Authors:  Emily Reeve; Danijela Gnjidic; Janet Long; Sarah Hilmer
Journal:  Br J Clin Pharmacol       Date:  2015-12       Impact factor: 4.335

4.  Prevalence and factors associated with polypharmacy in older people with cancer.

Authors:  Justin P Turner; Sepehr Shakib; Nimit Singhal; Jonathon Hogan-Doran; Robert Prowse; Sally Johns; J Simon Bell
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.